Armata Pharmaceuticals, Inc. Common Stock (ARMP)
SG&A Expense Growth
51.20%
Quarterly · Period ending:
ARMP SG&A Expense Growth
Latest reported51.20%period ending
Latest reported51.20%period ending
ARMP Quarterly SG&A Growth (QoQ) (0.00% → 51.20%)
Latest values, visible window
High-resolution chart · PNG
ARMP sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 51.1984% | |
| 1.08% | |
| 10.1254% | |
| 18.7858% | |
| -19.4897% | |
| -2.1065% | |
| 2.4353% | |
| -5.6703% | |
| 8.2127% | |
| -0.0315% | |
| -5.4432% | |
| 56.3721% | |
| -15.2876% | |
| 40.221% | |
| 15.9513% | |
| -25.06% | |
| 5.0429% | |
| -10.7962% | |
| 25.7353% | |
| -17.3446% | |
| -0.5579% | |
| 8.8012% | |
| 7.1545% | |
| -6.4876% | |
| -9.1202% | |
| 24.5554% | |
| -53.6189% | |
| 80.4995% | |
| 50.8696% | |
| -6.4407% | |
| 15.5956% | |
| -6.1765% | |
| -14.5192% | |
| 22.8571% | |
| -19.7148% | |
| -42.0618% | |
| 46.6807% | |
| 23.4873% | |
| -13.7002% | |
| -27.3358% | |
| -7.2995% | |
| 42.6875% | |
| 0.5426% | |
| 13.9765% | |
| 15.748% | |
| 6,173.913% | |
| -101.3521% | |
| -20.9205% | |
| 32.2065% | |
| -59.6978% | |
| 232.2634% | |
| -57.2635% | |
| 298.1793% | |
| 0% | |
| 30.5019% | |
| -23.8795% | |
| 42.2153% | |
| -21.8137% | |
| -30.137% | |
| -7.2525% | |
| -14.4475% | |
| 30.3424% | |
| 7.5556% | |
| 1.482% | |
| -5.7108% | |
| -2.4303% | |
| 7.5893% | |
| 5.8744% | |
| 15.8842% | |
| -14.2282% | |
| -10.241% | |
| -11.9363% | |
| 38.8071% | |
| -7.9946% | |
| -28.5576% | |
| 18.0571% | |
| 10.5496% | |
| 39.7176% | |
| -21.21% | |
| 7.6347% | |
| -63.0224% | |
| 195.6628% | |
| -22.6092% | |
| -34.071% | |
| 89.1785% | |
| -13.7602% | |
| 1.8031% | |
| -28.8604% | |
| -15.1883% | |
| 113.5836% | |
| 2.4725% | |
| -1.355% | |
| 155.35% | |
| -300% | |
| 42.8571% | |
| -12.5% | |
| -11.1111% | |
| 28.5714% | |
| 0% | |
| -12.5% |